This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December 6, 2024.
Alba Bioscience holds two significant Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs (VA) under the GSA Schedule 65-VII, one with a ceiling value of $109,420.35 through September 2029 for red blood cell reagents, and another with a potential value of $30,000 through September 2028 for blood bank reagents. These contracts demonstrate Alba Bioscience's established position as a trusted supplier of essential medical products to federal healthcare systems, including the VA, DLA, and Department of Health and Human Services (HHS).
Generated 3/4/25, 11:36 AM